Pasquale Comella, MD | Authors

Klinik St. Marienstift

Harsdorfer Strasse 30

Magdeburg

Articles

Triple- vs Double-Agent Chemotherapy for Advanced Non–Small-Cell Lung Cancer

July 01, 2000

In our previous phase I/II studies, both the cisplatin (Platinol), gemcitabine (Gemzar), and vinorelbine (Navelbine) (PGV), and cisplatin, gemcitabine, and paclitaxel (Taxol) (PGT) regimens produced a median survival of